Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules

Journal of Neuroimmunology

Volumn 128, Issue 1-2, 2002, Pages 82-89

  Romi, Fredrik ^a   Bo, Lars ^a   Skeie, Geir Olve ^a   Myking, Andreas ^a   Aarli, Johan A ^a   Gilhus, Nils Erik ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

B7; LFA3; Myasthenia gravis; Ryanodine receptor; Thymoma; Titin

Indexed keywords

ANTIBODY; B7 ANTIGEN; CHOLINERGIC RECEPTOR; CONNECTIN RECEPTOR; EPITOPE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; RECEPTOR; RYANODINE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HUMAN; MALE; MICROENVIRONMENT; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STAINING; T LYMPHOCYTE; THYMOMA;

ADULT; AGED; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD58; ANTIGENS, CD80; AUTOANTIBODIES; CHILD, PRESCHOOL; DOGS; EPITHELIAL CELLS; EPITOPES; FEMALE; GENE EXPRESSION; HUMANS; INFANT; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYASTHENIA GRAVIS; PROTEIN KINASES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THYMOMA; THYMUS NEOPLASMS;

EID: 0036295743     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00145-5     Document Type: Article

References (34)

1. Accessory molecule expression in human thymomas and thymus
2. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma
3. Towards an integrated view of thymopoesis
4. Effect of costimulation and the microenvironment on antigen presentation by leukemic cells
5. The development of CD4+ T effector cells during the type 2 immune response
6. Rabbit antiserum to citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients
7. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T-cells
8. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
9. Early-onset myasthenia gravis: A recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a
10. New approaches to the diagnosis of thymic epithelial tumors
11. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness
12. Determination of acetylcholine receptor antibody in myasthenia gravis - Clinical usefulness and pathogenic implications
13. Analysis of the acetylcholine receptor epitope-bearing protein p153 in thymomas favours 'false-positive T-cell selection' as a mechanism of paraneoplastic myasthenia gravis
14. A striational muscle antigen and myasthenia gravis-associated thymomas share an acetylcholine-receptor epitope
15. Distribution of molecules mediating thymocyte-stroma-interaction in human thymus, thymitis and thymic epithelial tumors
16. Pathogenesis of myasthenia gravis
17. The pathological basis of thymoma associated myasthenia gravis
18. Thymomas express epitopes shared by the ryanodine receptor
19. Differential expression of homing-associated adhesion molecules by T cell subsets in man
20. Immune regulation and myasthenia gravis
21. Muscle autoantibodies in subgroups of myasthenia gravis patients
22. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies
23. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations
24. Neurofilament is an autoantigenic determinant in myasthenia gravis
25. Risk factors for acquired myasthenia gravis in dogs: 1,154 cases (1991-1995)
26. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis
27. Titin antibodies in patients with late onset myasthenia gravis: Clinical correlations
28. Ryanodine receptor antibodies are associated with severe myasthenia gravis
29. Titin transcripts in thymoma
30. 2+ release channel (ryanodine receptor) in myasthenia gravis: Epitope mapping and functional effect on calcium release from sarcoplasmic reticulum in vitro
31. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T-cells
32. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo
33. The role of T-cells in the initiation of autoantibody responses in thymoma patients
34. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis